ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,658.53
      1.33%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      02/16/20164:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/16/20164:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/16/20164:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/16/20162:52PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/12/20169:22AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/04/20164:05PMPR Newswire (US)Blueprint Medicines Appoints Lonnel Coats to Board of DirectorsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/22/20164:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/07/20168:00AMPR Newswire (US)Lexicon To Present At The 34th Annual J.P. Morgan Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/07/20157:00AMPR Newswire (US)Lexicon To Present At The Oppenheimer 26th Annual Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/01/20158:07AMPR Newswire (US)Telotristat Etiprate Achieves Positive Top-Line Results In Second Phase 3 Clinical TrialNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/18/20155:00PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/12/20158:00AMPR Newswire (US)Lexicon To Present At The Stifel 2015 Healthcare Conference And The Jefferies 2015 Global Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/09/20158:13AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/06/20152:35PMThe Motley FoolLexicon Pharmaceuticals Explodes Higher -- Here's What's Fueling the SurgeNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/06/201512:54PMDow Jones NewsLexicon, Sanofi Agree to Diabetes Drug PactNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/06/20158:00AMPR Newswire (US)Sanofi and Lexicon Pharmaceuticals To Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diab...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/06/20156:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/06/20156:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/06/20156:00AMPR Newswire (US)Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi For SotagliflozinNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/06/20151:01AMPR Newswire (US)Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diab...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/05/20154:01PMPR Newswire (US)Lexicon To Report Third Quarter 2015 Financial Results On November 6, 2015NASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/19/20157:00AMPR Newswire (US)Cancer Patients Treated With Lexicon's Telotristat Etiprate Report Improved Function And Well-BeingNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/14/20156:02AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/14/20156:02AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/09/20158:00AMPR Newswire (US)Lexicon Announces Telotristat Etiprate Data To Be Presented At North American Neuroendocrine Tumor Society Annual SymposiumNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/29/20156:00AMPR Newswire (US)Lexicon's Telotristat Etiprate Shows Clinical Benefit In Treating Carcinoid Syndrome In Cancer Patients When Added To Standar...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/28/20158:00AMPR Newswire (US)Media Alert: Lexicon To Discuss Complete Results Of Pivotal Phase 3 TELESTAR StudyNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/08/20157:00AMPR Newswire (US)Lexicon Announces Sotagliflozin Data To Be Presented At European Association For The Study Of DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/26/20158:00AMPR Newswire (US)Lexicon Announces Telotristat Etiprate Data To Be Presented At European Cancer CongressNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/25/201511:51AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX